Document is current
Any future updates will be listed below
-
Authors
Reinwarth, Anna Celine
Wicke, Felix S.
Rückert, Kamiar K.
Schattenberg, Jörn M.
Tüscher, Oliver
Wild, Philipp S.
Münzel, Thomas
König, Jochem
Lackner, Karl J.
Pfeiffer, Norbert
Beutel, Manfred E.
-
Funding
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 11 August 2024
First Online: 23 August 2024
Declarations
:
: The protocol and documents of the study were approved by the local data safety commissioner and by the ethics committee of the Medical Chamber of Rhineland-Palatinate (reference no. 2018–13720; original vote: December 12, 2017, latest update: September 27, 2021). Study investigations were all conducted in line with the Declaration of Helsinki and principles outlined in recommendations for Good Clinical Practice and Good Epidemiological Practice. Written informed consent was obtained from each participant before their inclusion in the study.
: Not applicable.
: J.M.S. declares consulting honoraria from Akero, 89Bio, Boehringer Ingelheim, Ipsen, Inventiva Pharma, Madrigal, Northsea Therapeutics, Novo Nordisk, Roche, Siemens Healthineers, research Funding from Boehringer Ingelheim and speaker Honoraria from Novo Nordisk, Madrigal, MedPublico GmbH. The others authors declare none.
